Mr. McAdam first joined Camber in 2020 and was named CEO in November, according to the company’s website.
Mr. McAdam has played a critical role in the development and growth of Camber’s oblique lateral interbody fusion portfolio, restructured the company’s supply chain and led the growth of its sales team.
He previously served as Camber’s vice president of operations and COO. He has held roles at Medtronic and Globus Medical.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
